Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
X8w45v3pMp56Gtex